Digital PCR Market Size is Poised to Reach US$ 7.9 Billion by 2028

Industry Overview of Digital PCR Market

Digital polymerase chain reaction, or digital PCR (dPCR), represents an endpoint, high-throughput absolute quantitative analytics that aids in measuring the DNA or RNA count of a given sample in a precise and sensitive way. Compared to its traditional counterparts, digital PCR uses a wide range of methods, such as droplet-based, chip-based, and beaming dPCR, to facilitate various applications. As a result, digital PCR methods are extensively used in basic and diagnostic research, including human genetic testing, pathogen detection, and forensic sciences.

How Big Is the Digital PCR Market?

The global digital PCR market size reached US$ 4.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.9 Billion by 2028, exhibiting a growth rate (CAGR) of 10.5% during 2023-2028.

Global Industry Trends and Drivers:

The inflating healthcare expenditure on molecular diagnosis across the globe, on account of the growing prevalence of numerous diseases, including genetic disorders, COVID-19, lung cancer, brain tumors, etc., is among the primary factors driving the digital PCR market. Besides this, the escalating demand for early diagnosis and treatment has resulted in extensive R&D that focuses on genetic technologies, which is further augmenting the market growth. Moreover, continuous technological advancements in PCR technologies and the development of innovative devices for droplet, chip-based, beam, and crystal dPCR by the leading players are also catalyzing the global market. Apart from this, the widespread utilization of these devices in reference laboratories for detecting genetic mutations and identifying pathogens is acting as another significant growth-inducing factor. Furthermore, the launch of favorable initiatives undertaken by governmental and federal agencies across the globe, the shifting preferences from plant-derived to genome-based drug discovery, and the rising applications of these instruments in food microbiology and veterinary medicine are anticipated to propel the digital PCR market over the forecasted period.

Request a free sample of report: https://www.imarcgroup.com/digital-pcr-market/requestsample

What Is Included In Market Segmentation?

The report has been segmented the market into following categories:

Breakup by Product Type:

• Digital PCR Equipment
• Consumables and Reagents
• Software and Services

Breakup by Technology:

• Droplet Digital PCR
• BEAMing Digital PCR

Breakup by Application:

• Clinical Diagnostics
• Forensics
• Research
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

The report provides a comprehensive analysis of the industry key players listed below:

Avance Biosciences Inc., Bio-Rad Laboratories Inc., Danaher Corporation, JN Medsys, OPTOLANE Technologies Inc., QIAGEN, SAGA Diagnostics AB, Standard BioTools Inc., Stilla Technologies, Sysmex Corporation and Thermo Fisher Scientific Inc.

Ask Analyst for 10% free customized report: https://www.imarcgroup.com/request?type=report&id=5897&flag=C

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800